Literature DB >> 7521256

Induction of nitric oxide synthase in cultured vascular smooth muscle cells: the role of cyclic AMP.

K Hirokawa1, K O'Shaughnessy, K Moore, P Ramrakha, M R Wilkins.   

Abstract

1. Interleukin-1 beta (IL-1 beta) is a potent stimulant of inducible nitric oxide synthase (iNOS) mRNA and nitric oxide (NO) production in vascular smooth muscle (VSM) cells in culture. These studies investigate the role of adenosine 3':5'-cyclic monophosphate (cyclic AMP) in this process. 2. Dibutyryl cyclic AMP (db cyclic AMP, 0.1-1 mM), forskolin (1-10 microM) and the phosphodiesterase inhibitor, Ro 20-1724 (1-10 microM), all of which increase intracellular cyclic AMP, had no effect on NO production when added alone but markedly enhanced NO production by IL-1 beta-stimulated VSM cells in a dose-dependent manner. Consistent with a cyclic AMP-mediated action, isoprenaline (1-10 microM) increased NO production from IL-1 beta-stimulated cells. Dibutyryl cyclic GMP (db cyclic GMP) had no effect at concentrations up to 1 mM. 3. Pursuing these observations, iNOS protein levels were examined by Western blot analysis and iNOS mRNA levels were measured by reverse transcription and amplification of the resultant cDNA using the polymerase chain reaction. In addition to enhancing NO production, db cyclic AMP increased iNOS protein and mRNA above that produced by IL-1 beta alone. 4. These data demonstrate a major effect of cyclic AMP on cytokine-induced NOS activity in VSM cells, mediated at least in part by regulating synthesis of iNOS, and has implications for the pathogenesis and management of septic shock.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7521256      PMCID: PMC1910341          DOI: 10.1111/j.1476-5381.1994.tb13085.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells.

Authors:  R Busse; A Mülsch
Journal:  FEBS Lett       Date:  1990-11-26       Impact factor: 4.124

2.  Phosphorylation by calcium calmodulin-dependent protein kinase II and protein kinase C modulates the activity of nitric oxide synthase.

Authors:  M Nakane; J Mitchell; U Förstermann; F Murad
Journal:  Biochem Biophys Res Commun       Date:  1991-11-14       Impact factor: 3.575

Review 3.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

Review 4.  Molecular mechanisms of nitric oxide regulation. Potential relevance to cardiovascular disease.

Authors:  J L Dinerman; C J Lowenstein; S H Snyder
Journal:  Circ Res       Date:  1993-08       Impact factor: 17.367

5.  Nitric oxide synthase. Structural studies using anti-peptide antibodies.

Authors:  V Riveros-Moreno; C Beddell; S Moncada
Journal:  Eur J Biochem       Date:  1993-08-01

6.  Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB.

Authors:  K K Yamamoto; G A Gonzalez; W H Biggs; M R Montminy
Journal:  Nature       Date:  1988-08-11       Impact factor: 49.962

7.  Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells.

Authors:  D Beasley; J H Schwartz; B M Brenner
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

8.  Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. Synergism with the induction elicited by inflammatory cytokines.

Authors:  M Koide; Y Kawahara; I Nakayama; T Tsuda; M Yokoyama
Journal:  J Biol Chem       Date:  1993-11-25       Impact factor: 5.157

9.  Regulation of nitric oxide production by stimulated rat Kupffer cells.

Authors:  T Gaillard; A Mülsch; R Busse; H Klein; K Decker
Journal:  Pathobiology       Date:  1991       Impact factor: 4.342

10.  Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat.

Authors:  L A Brown; D J Nunez; M R Wilkins
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

View more
  11 in total

Review 1.  The hepatorenal syndrome.

Authors:  L Dagher; K Moore
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

2.  Effect of cyclic GMP-dependent vasodilators on the expression of inducible nitric oxide synthase in vascular smooth muscle cells: role of cyclic AMP.

Authors:  M Boese; R Busse; A Mülsch; V Schini-Kerth
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

3.  Platelet-derived growth factor and fibroblast growth factor differentially regulate interleukin 1beta- and cAMP-induced nitric oxide synthase expression in rat renal mesangial cells.

Authors:  D Kunz; G Walker; W Eberhardt; U K Messmer; A Huwiler; J Pfeilschifter
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

4.  Autocrine growth inhibition of IL-1 beta-treated cultured human aortic smooth muscle cells: possible role of nitric oxide.

Authors:  S Makita; M Nakamura; H Yoshida; K Hiramori
Journal:  Heart Vessels       Date:  1996       Impact factor: 2.037

5.  Inhibition of cytokine-induced inducible nitric oxide synthase expression by glucagon and cAMP in cultured hepatocytes.

Authors:  F S Smith; E D Ceppi; M A Titheradge
Journal:  Biochem J       Date:  1997-08-15       Impact factor: 3.857

6.  Cytoskeleton-dependent activation of the inducible nitric oxide synthase in cultured aortic smooth muscle cells.

Authors:  N Marczin; T Jilling; A Papapetropoulos; C Go; J D Catravas
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

7.  Effect of cyclic AMP and prostaglandin E2 on the induction of nitric oxide- and prostanoid-forming pathways in cultured rat mesangial cells.

Authors:  R M Nüsing; T Klein; J Pfeilschifter; V Ullrich
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

Review 8.  The hepatorenal syndrome.

Authors:  G Van Roey; K Moore
Journal:  Pediatr Nephrol       Date:  1996-02       Impact factor: 3.714

9.  Crth2 receptor signaling down-regulates lipopolysaccharide-induced NF-κB activation in murine macrophages via changes in intracellular calcium.

Authors:  Bastihalli T Diwakar; Ryan Yoast; Shaneice Nettleford; Fenghua Qian; Tai-Jung Lee; Svanjita Berry; Ian Huffnagle; Randall M Rossi; Mohamed Trebak; Robert F Paulson; K Sandeep Prabhu
Journal:  FASEB J       Date:  2019-09-13       Impact factor: 5.191

10.  Cyclooxygenase-2 and its regulation in inflammation.

Authors:  Y S Bakhle; R M Botting
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.